Analyst Consensus ?
ConsensusBuy44 ratings
Bullish3068.2%
Neutral1431.8%
Bearish00.0%
Microchip Technology Incorporated · MCHP · FY2027 Q1 · Calendar Q3 2026
Microchip beats guidance as data center drives Q2 FY2027 growth
Microchip's Q2 evidence supports a constructive growth narrative: data center was a major driver, other end markets improved, and management maintained an ambitious near-term outlook. The counterevidence is that supply constraints, inventory normalization, one-time pricing and licensing benefits, and uncertain demand durability make the next-year trajectory dependent on execution and sustained demand.
Reported After market closeNASDAQTechnology
$40.61B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.76
Consensus $0.70
EPS surprise
+8.6%
Reported versus consensus
Reported revenue
$1.48B
Consensus $1.46B
Revenue surprise
+1.8%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+13.9%
Event window
SPY move
+0.6%
Same window
Abnormal move
+13.3%
Stock minus SPY
Volume
1.7×
Versus trailing sessions
Subsequent drift
-12.4%
Up to 20 sessions
MCHPSPY benchmark
Ask FN2 about MCHP FY2027 Q1
Transcript, numbers and history already loaded
Why did MCHP rise 13.9% after beating EPS estimates in FY2027 Q1?What changed in MCHP's guidance and outlook in FY2027 Q1?Give me the bull and bear case for MCHP after FY2027 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, the narrative shifted from recovery supported by automotive Ethernet, FPGA, licensing, memory, and PCIe design wins to a stronger data-center-led upturn. Management added the Hailo acquisition to its AI-on-edge roadmap, reported ongoing capacity constraints, and continued to emphasize debt reduction and roughly $100 million of FY27 capex.
Guidance delta
Management maintained its outlook, reaffirming an 8% sequential revenue rise and 66–67% non-GAAP gross-margin guidance for Q3.
Key takeaways
- Microchip's Q2 FY2027 results beat the high end of guidance, with non-GAAP EPS of $0.76 and revenue of $1.485 billion.
- Data-center sales grew 97% year over year and management highlighted a pipeline that could take exposure to about $1 billion.
- Industrial, aerospace and defense, and automotive demand also showed strength, broadening the growth contribution.
- Supply constraints, inventory normalization, and one-time pricing and licensing benefits complicate the durability of the current margin and sales trajectory.
Management priorities
- Launch and ramp PCIe Gen6 switches, retimers, and NVMe controllers in FY27.
- Integrate the Hailo acquisition into the AI-on-edge product roadmap.
- Continue debt reduction while keeping FY27 capital spending around $100 million.
- Expand internal capacity and testing capabilities while improving visibility into end-market sales and design wins.
Follow MCHP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$74.78Previous close
$61Low
$95.1Average
$135High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BMO Capital | Outperform | Outperform | Maintain | Aug 21, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Aug 17, 2026 |
| UBS | Buy | Buy | Maintain | Aug 7, 2026 |
| Truist Securities | Hold | Hold | Maintain | Aug 7, 2026 |
| Rosenblatt | Buy | Buy | Maintain | Aug 7, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 7, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 20, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jul 13, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 11, 2026 |
| Susquehanna | Positive | Positive | Maintain | May 8, 2026 |
| Needham | Buy | Buy | Maintain | May 8, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 8, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 8, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Feb 6, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jan 21, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jan 15, 2026 |
| B. Riley Securities | Buy | Buy | Maintain | Jan 12, 2026 |
| Stifel | Buy | Buy | Maintain | Jan 6, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jan 6, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Aug 8, 2025 |
| Keybanc | Overweight | Overweight | Maintain | Jul 8, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 10, 2025 |
| Jefferies | Buy | Buy | Maintain | Nov 6, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 18, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 3, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Aug 3, 2022 |
| Longbow Research | Buy | Neutral | Upgrade | Mar 23, 2021 |
| B. Riley FBR | Buy | Buy | Maintain | Feb 5, 2021 |
| Vertical Research | Neutral | Buy | Downgrade | Feb 3, 2021 |
| Suntrust Robinson Humphrey | Buy | Buy | Maintain | Jun 3, 2020 |
| CFRA | Hold | Hold | Maintain | May 8, 2020 |
| B. Riley | Buy | Buy | Maintain | Nov 6, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Sep 17, 2018 |
| Nomura | Buy | Buy | Maintain | Aug 10, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jul 27, 2018 |
| Argus | Buy | Buy | Maintain | Oct 6, 2017 |
| Summit Redstone Partners | Buy | Hold | Upgrade | Apr 4, 2017 |
| Summit Insights Group | Buy | Hold | Upgrade | Apr 4, 2017 |
| CLSA | Buy | Buy | Maintain | May 17, 2016 |
| Stifel Nicolaus | Buy | Buy | Maintain | Aug 4, 2015 |
| Drexel Hamilton | Hold | Buy | Downgrade | Oct 10, 2014 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Nov 18, 2013 |
| ISI Group | Strong Buy | Buy | Upgrade | Mar 4, 2013 |
| Miller Tabak | Neutral | Neutral | Maintain | Oct 16, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $74.78. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $90 | $84.81 | +20.4% | Aug 7, 2026 |
| UBS | Analyst unavailable | $120 | $74.36 | +60.5% | Aug 7, 2026 |
| Jefferies | Analyst unavailable | $100 | $74.36 | +33.7% | Aug 7, 2026 |
| Wells Fargo | Joe Quatrochi | $88 | $80.96 | +17.7% | Jul 20, 2026 |
| Barclays | Tom O'Malley | $105 | $99.09 | +40.4% | May 11, 2026 |
| UBS | Analyst unavailable | $130 | $97.97 | +73.8% | May 8, 2026 |
| Needham | Quinn Bolton | $120 | $98.64 | +60.5% | May 8, 2026 |
| Susquehanna | Analyst unavailable | $120 | $99.59 | +60.5% | May 8, 2026 |
| Truist Financial | William Stein | $105 | $98.7 | +40.4% | May 8, 2026 |
| Morgan Stanley | Analyst unavailable | $94 | $99.6 | +25.7% | May 8, 2026 |
| Raymond James | Melissa Fairbanks | $125 | $99.58 | +67.2% | May 8, 2026 |
| Evercore ISI | Mark Lipacis | $117 | $101.14 | +56.5% | May 8, 2026 |
| Mizuho Securities | Analyst unavailable | $112 | $101.58 | +49.8% | May 8, 2026 |
| KeyBanc | Analyst unavailable | $135 | $101.58 | +80.5% | May 8, 2026 |
| Jefferies | Analyst unavailable | $120 | $101.58 | +60.5% | May 8, 2026 |
| Barclays | Tom O'Malley | $80 | $80.75 | +7.0% | Feb 12, 2026 |
| Truist Financial | Analyst unavailable | $69 | $76.86 | -7.7% | Feb 10, 2026 |
| Stifel Nicolaus | Tore Svanberg | $90 | $75.58 | +20.4% | Feb 6, 2026 |
| Cantor Fitzgerald | Matthew Prisco | $100 | $75.54 | +33.7% | Feb 6, 2026 |
| Truist Financial | Analyst unavailable | $68 | $75.28 | -9.1% | Feb 6, 2026 |
| KeyBanc | John Vinh | $85 | $75.96 | +13.7% | Feb 6, 2026 |
| Evercore ISI | Mark Lipacis | $93 | $74.21 | +24.4% | Feb 6, 2026 |
| Mizuho Securities | Analyst unavailable | $90 | $78.04 | +20.4% | Feb 6, 2026 |
| Needham | Analyst unavailable | $84 | $78.04 | +12.3% | Feb 6, 2026 |
| Industrial Alliance Securities | Analyst unavailable | $100 | $77.12 | +33.7% | Feb 2, 2026 |
| UBS | Analyst unavailable | $95 | $74.7 | +27.0% | Jan 26, 2026 |
| Susquehanna | Analyst unavailable | $90 | $74.91 | +20.4% | Jan 22, 2026 |
| BNP Paribas | David O'Connor | $90 | $76.2 | +20.4% | Jan 22, 2026 |
| UBS | Analyst unavailable | $78 | $75.51 | +4.3% | Jan 21, 2026 |
| Piper Sandler | Analyst unavailable | $85 | $74.68 | +13.7% | Jan 15, 2026 |
| Mizuho Securities | Analyst unavailable | $83 | $74.06 | +11.0% | Jan 9, 2026 |
| Morgan Stanley | Analyst unavailable | $69 | $74.87 | -7.7% | Jan 7, 2026 |
| Stifel Nicolaus | Tore Svanberg | $80 | $67.06 | +7.0% | Jan 6, 2026 |
| Wolfe Research | Analyst unavailable | $85 | $67.06 | +13.7% | Jan 6, 2026 |
| Mizuho Securities | Vijay Rakesh | $80 | $67.2 | +7.0% | Dec 16, 2025 |
| Cantor Fitzgerald | CJ Muse | $85 | $67.2 | +13.7% | Dec 16, 2025 |
| Needham | Analyst unavailable | $75 | $63.99 | +0.3% | Dec 4, 2025 |
| Truist Financial | William Stein | $60 | $56.28 | -19.8% | Nov 9, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $65 | $55.34 | -13.1% | Nov 7, 2025 |
| Morgan Stanley | Joseph Moore | $68 | $60.25 | -9.1% | Nov 4, 2025 |
| Needham | Quinn Bolton | $77 | $62.97 | +3.0% | Aug 8, 2025 |
| Raymond James | Melissa Fairbanks | $75 | $61.87 | +0.3% | Aug 8, 2025 |
| Cantor Fitzgerald | Matthew Prisco | $70 | $68.02 | -6.4% | Jun 18, 2025 |
| Evercore ISI | Mark Lipacis | $83 | $67.93 | +11.0% | Jun 12, 2025 |
| Truist Financial | Analyst unavailable | $43 | $39.43 | -42.5% | Apr 21, 2025 |
| Mizuho Securities | Analyst unavailable | $68 | $58.14 | -9.1% | Mar 4, 2025 |
| Morgan Stanley | Joseph Moore | $58 | $52.6 | -22.4% | Feb 4, 2025 |
| KeyBanc | Weston Twigg | $90 | $70.31 | +20.4% | Dec 3, 2024 |
| Truist Financial | William Stein | $71 | $74.4 | -5.1% | Nov 6, 2024 |
| Needham | Rajvindra Gill | $85 | $74.4 | +13.7% | Nov 6, 2024 |
| Evercore ISI | Mark Lipacis | $95 | $74.4 | +27.0% | Nov 6, 2024 |
| KeyBanc | Weston Twigg | $95 | $74.4 | +27.0% | Nov 6, 2024 |
| Raymond James | Melissa Fairbanks | $95 | $74.4 | +27.0% | Nov 6, 2024 |
| Mizuho Securities | Vijay Rakesh | $95 | $76.58 | +27.0% | Oct 18, 2024 |
| Truist Financial | William Stein | $80 | $77.01 | +7.0% | Sep 23, 2024 |
| Citigroup | Christopher Danely | $92 | $80.28 | +23.0% | Aug 21, 2024 |
| Rosenblatt Securities | Hans Mosesmann | $90 | $74.67 | +20.4% | Aug 5, 2024 |
| Mizuho Securities | Vijay Rakesh | $115 | $98.14 | +53.8% | May 23, 2024 |
| Piper Sandler | Harsh Kumar | $90 | $93.02 | +20.4% | May 7, 2024 |
| Needham | Rajvindra Gill | $100 | $93.76 | +33.7% | May 7, 2024 |
| Mizuho Securities | Vijay Rakesh | $85 | $93.76 | +13.7% | May 7, 2024 |
| Evercore ISI | Mark Lipacis | $106 | $85.7 | +41.7% | Apr 15, 2024 |
| Wolfe Research | Chris Caso | $105 | $83.34 | +40.4% | Jan 17, 2024 |
| Credit Suisse | Analyst unavailable | $85 | $76.94 | +13.7% | Nov 16, 2022 |
| Piper Sandler | Harsh Kumar | $80 | $59.46 | +7.0% | Nov 3, 2022 |
| Goldman Sachs | Toshiya Hari | $61 | $65.31 | -18.4% | Jul 27, 2022 |
| Stifel Nicolaus | Tore Svanberg | $75 | $59.45 | +0.3% | Jun 28, 2022 |
| BMO Capital | Ambrish Srivastava | $85 | $68.25 | +13.7% | May 11, 2022 |
| Wells Fargo | Gary Mobley | $80 | $72.92 | +7.0% | Feb 4, 2022 |
| B.Riley Financial | Craig Ellis | $105 | $72.92 | +40.4% | Feb 4, 2022 |
| Needham | Rajvindra Gill | $105 | $72.92 | +40.4% | Feb 4, 2022 |
| Cowen & Co. | Matt Ramsay | $78 | $72.92 | +4.3% | Feb 4, 2022 |
| BMO Capital | Ambrish Srivastava | $95 | $72.92 | +27.0% | Feb 4, 2022 |
| Citigroup | Christopher Danely | $78 | $72.92 | +4.3% | Feb 4, 2022 |
| Raymond James | Chris Caso | $110 | $85.22 | +47.1% | Nov 5, 2021 |
| Credit Suisse | John Pitzer | $120 | $85.22 | +60.5% | Nov 5, 2021 |
| Piper Sandler | Harsh Kumar | $100 | $85.22 | +33.7% | Nov 5, 2021 |
| Morgan Stanley | Joseph Moore | $100 | $85.22 | +33.7% | Nov 5, 2021 |
| KeyBanc | John Vinh | $92.5 | $72.38 | +23.7% | Jul 6, 2021 |
Track every rating change on MCHP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMicrochip Technology Incorporated creates, produces, and sells intelligent, interconnected, and secure embedded control solutions to customers throughout the Americas, Europe, and Asia. The company's core offerings include a range of microcontrollers, such as general-purpose 8-bit, 16-bit, and 32-bit models, as well as 32-bit embedded microprocessors. These specialized microcontrollers are designed for numerous applications across industries like automotive, industrial, computing, communications, lighting, power supplies, motor control, human-machine interfaces, security, and various wired and wireless connectivity needs. Beyond its processors, Microchip provides development tools that enable system designers to program its microcontroller and microprocessor units for specific tasks. Its product lineup also features Field-Programmable Gate Arrays (FPGAs) and a broad selection of analog, interface, mixed-signal, and timing components.…
Historical context
All MCHP earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
| SAIL SailPoint, Inc. | FY2027 Q2 · Calendar Q3 2026 | +13.8% | -1.2% | SailPoint pairs 25% ARR growth with accelerating AI-driven adoption |
| CIEN Ciena Corporation | FY2026 Q3 · Calendar Q3 2026 | +22.0% | -10.4% | Ciena raises outlook as AI networking demand lifts backlog |
| DOCU DocuSign, Inc. | FY2027 Q2 · Calendar Q3 2026 | +6.4% | +3.7% | DocuSign Q2 FY27: IAM momentum supports a raised outlook |
| IOT Samsara Inc. | FY2027 Q2 · Calendar Q3 2026 | +25.0% | +3.7% | Samsara: AI adoption expands as FY27 guidance holds |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the MCHP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-09T00:14:34.720340+00:00
- FN2 earnings calendar · 2026-09-11T01:23:15.000588+00:00
- Polygon adjusted daily market bars · 2026-09-22T07:10:52.507909+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-22T07:10:52.504963+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.